Huaren Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	222.89	163.81	232.04	221.71	417.15	228.67
Cash & Short-Term Investments	222.89	163.81	232.04	221.71	417.15	228.67
Cash Growth	85.59%	-29.40%	4.66%	-46.85%	82.42%	-40.10%
Accounts Receivable	598.98	628.45	806.11	739.22	887.34	707.35
Other Receivables	37.07	34.71	1,364	1,430	1,419	273.01
Receivables	636.05	663.15	2,170	2,169	2,306	980.36
Inventory	252.56	318.24	334.63	266.85	275.47	258.96
Other Current Assets	50.88	39.77	54.51	71.8	109.27	129.16
Total Current Assets	1,162	1,185	2,791	2,730	3,108	1,597
Property, Plant & Equipment	1,080	1,076	1,116	1,139	1,219	1,272
Long-Term Investments	15.98	16.58	16.58	16.58	16.58	16.58
Goodwill	732.61	732.61	820.04	826.29	826.64	283.64
Other Intangible Assets	288.91	301.7	318.53	331.77	366.16	155.51
Long-Term Deferred Tax Assets	59.48	57.19	42.03	56.87	46.4	34.31
Long-Term Deferred Charges	11.81	18.13	29.1	27.15	22.6	29.3
Other Long-Term Assets	45.66	40.88	32.13	35.72	36.58	26.67
Total Assets	3,397	3,428	5,166	5,163	5,642	3,416
Accounts Payable	115.5	147.35	142.32	122.75	127.08	137.88
Accrued Expenses	17.35	185.72	192.22	206.03	183.32	113.29
Short-Term Debt	485.93	424.41	624.83	1,218	1,579	536.65
Current Portion of Long-Term Debt	-	389.02	101.8	98.96	29.96	-
Current Portion of Leases	-	-	0.59	1.08	0.86	-
Current Income Taxes Payable	15.87	9.83	15.93	32.78	28.54	18.01
Current Unearned Revenue	33.12	32.46	55.55	32	28.17	20.43
Other Current Liabilities	894.9	357.84	383.01	317.41	613.99	229.2
Total Current Liabilities	1,563	1,547	1,516	2,029	2,591	1,055
Long-Term Debt	366.13	464.08	836.42	352.74	230.36	-
Long-Term Leases	0.96	-	0.16	0.41	0.26	-
Long-Term Unearned Revenue	0.13	0.13	0.18	0.72	2.77	5.52
Long-Term Deferred Tax Liabilities	41.06	43.35	46.72	50.93	55.87	25.05
Other Long-Term Liabilities	-	-	-	128.86	318.11	-
Total Liabilities	1,971	2,054	2,400	2,563	3,198	1,086
Common Stock	1,182	1,182	1,182	1,182	1,182	1,182
Additional Paid-In Capital	528.04	528.04	528.04	528.04	528.04	528.04
Retained Earnings	-354.89	-409.47	983.83	820.59	661.09	548.41
Total Common Equity	1,355	1,301	2,694	2,531	2,371	2,259
Minority Interest	70.48	73.14	71.86	68.88	72.09	70.85
Shareholders' Equity	1,426	1,374	2,766	2,600	2,443	2,330
Total Liabilities & Equity	3,397	3,428	5,166	5,163	5,642	3,416
Total Debt	853.03	1,278	1,564	1,672	1,840	536.65
Net Cash (Debt)	-630.14	-1,114	-1,332	-1,450	-1,423	-307.98
Net Cash Per Share	-0.53	-0.94	-1.13	-1.23	-1.20	-0.26
Filing Date Shares Outstanding	1,182	1,182	1,182	1,182	1,182	1,182
Total Common Shares Outstanding	1,182	1,182	1,182	1,182	1,182	1,182
Working Capital	-400.29	-361.65	1,275	700.13	517.09	541.69
Book Value Per Share	1.15	1.10	2.28	2.14	2.01	1.91
Tangible Book Value	333.84	266.47	1,556	1,373	1,179	1,820
Tangible Book Value Per Share	0.28	0.23	1.32	1.16	1.00	1.54
Buildings	-	1,098	1,096	1,089	1,082	1,063
Machinery	-	1,378	1,347	1,385	1,401	1,333
Construction In Progress	-	61.9	41.95	23.36	7.7	11.81

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.